A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata

The document reported a case where topical ruxolitinib (0.6% cream) failed to induce hair growth in a 66-year-old patient with alopecia areata (AA). This contrasted with a previous success in a young patient with alopecia universalis (AU). The study highlighted the need to understand the factors contributing to variations in treatment response, including patient-specific intrinsic factors and treatment regimen-related extrinsic factors. It also suggested that oral administration of ruxolitinib might be more effective for severe cases of AA, AT, and AU compared to topical application.